Cargando…

PPARβ activation inhibits melanoma cell proliferation involving repression of the Wilms’ tumour suppressor WT1

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that strongly influence molecular signalling in normal and cancer cells. Although increasing evidence suggests a role of PPARs in skin carcinogenesis, only expression of PPARγ has been investigated in huma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michiels, Jean-François, Perrin, Christophe, Leccia, Nathalie, Massi, Daniela, Grimaldi, Paul, Wagner, Nicole
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Molecular and Genomic Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2842567/ https://www.ncbi.nlm.nih.gov/pubmed/20066433 http://dx.doi.org/10.1007/s00424-009-0776-6

Ejemplares similares

Implications of the Wilms’ Tumor Suppressor Wt1 in Cardiomyocyte Differentiation
por: Wagner, Nicole, et al.
Publicado: (2021)

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
por: Wagner, Kay-Dietrich, et al.
Publicado: (2019)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

Every Beat You Take—The Wilms′ Tumor Suppressor WT1 and the Heart
por: Wagner, Nicole, et al.
Publicado: (2021)

TSA downregulates Wilms tumor gene 1 (Wt1) expression at multiple levels
por: Makki, Mohammad Shahidul, et al.
Publicado: (2008)

Wilms’ Tumour gene 1 (WT1) as an immunotherapeutic target
por: Coosemans, A.
Publicado: (2011)

RNA polymerase III transcription is repressed in response to the tumour suppressor ARF
por: Morton, Jennifer P., et al.
Publicado: (2007)

The epithelial splicing regulator ESRP2 is epigenetically repressed by DNA hypermethylation in Wilms tumour and acts as a tumour suppressor
por: Legge, Danny, et al.
Publicado: (2021)

Diagnostic utility of Wilms’ tumour-1 protein (WT-1) immunostaining in paediatric renal tumours
por: Goyal, Surbhi, et al.
Publicado: (2016)

Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression
por: Wagner, Kay-Dietrich, et al.
Publicado: (2019)

Somatic glypican 3 (GPC3) mutations in Wilms' tumour
por: White, G R M, et al.
Publicado: (2002)

Peroxisome proliferator-activated receptor β activation promotes myonuclear accretion in skeletal muscle of adult and aged mice
por: Giordano, C., et al.
Publicado: (2009)

Wilms’ tumour suppressor gene 1 (WT1) is involved in the carcinogenesis of Lung cancer through interaction with PI3K/Akt pathway
por: Wang, Xi, et al.
Publicado: (2013)

The Wilms’ tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A(2) receptor gene in megakaryocytes
por: Gannon, AnneMarie M, et al.
Publicado: (2009)

The Wilms' Tumor Suppressor Protein WT1 Is Processed by the Serine Protease HtrA2/Omi
por: Hartkamp, Jörg, et al.
Publicado: (2010)

Long-term kidney function in children with Wilms tumour and constitutional WT1 pathogenic variant
por: Falcone, Maria Pia, et al.
Publicado: (2021)

The Wilms’ tumor (WT1) gene: Methods and protocols
por: Agrawal, Suraksha
Publicado: (2018)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2
por: Rapley, E A, et al.
Publicado: (2000)

Deducing the stage of origin of Wilms' tumours from a developmental series of Wt1-mutant mice
por: Berry, Rachel L., et al.
Publicado: (2015)

Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour
por: Astuti, D, et al.
Publicado: (2005)

The tumor suppressor WT1 drives progenitor cell progression and epithelialization to prevent Wilms tumorigenesis in human kidney organoids
por: Waehle, Verena, et al.
Publicado: (2021)

Deletion of the Wilms’ Tumor Suppressor Gene in the Cardiac Troponin-T Lineage Reveals Novel Functions of WT1 in Heart Development
por: Díaz del Moral, Sandra, et al.
Publicado: (2021)

Appropriate Amounts and Activity of the Wilms’ Tumor Suppressor Gene, wt1, Are Required for Normal Pronephros Development of Xenopus Embryos
por: Shiraki, Taisei, et al.
Publicado: (2022)

Wilms’ Tumour 1 (WT1) peptide vaccination in patients with acute myeloid leukaemia induces short-lived WT1-specific immune responses
por: Uttenthal, Benjamin, et al.
Publicado: (2014)

Wilms Tumor-1 (WT1) rs16754 Polymorphism
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
por: Cowell, J. K., et al.
Publicado: (1993)

Wilms’ tumor suppressor gene (WT1) suppresses apoptosis by transcriptionally downregulating BAX expression in immature rat granulosa cells
por: Park, Minji, et al.
Publicado: (2014)

Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours
por: Satoh, Y, et al.
Publicado: (2006)

Wilms' Tumour
por: Pearson, D.
Publicado: (1976)

The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells
por: Han, Youqi, et al.
Publicado: (2007)

Circulating microRNA profiles in Wilms tumour (WT): A systematic review and meta-analysis of diagnostic test accuracy
por: Benlhachemi, Sara, et al.
Publicado: (2023)

WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type
por: Andikyan, Vaagn, et al.
Publicado: (2009)

Chemotherapy and terminal skeletal muscle differentiation in WT1‐mutant Wilms tumors
por: Royer‐Pokora, Brigitte, et al.
Publicado: (2018)

Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
por: Xu, Y, et al.
Publicado: (2012)

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
por: Dopeso, Higinio, et al.
Publicado: (2018)

SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours
por: Singh, K P, et al.
Publicado: (2006)

Commentary: LACTB is a tumour suppressor that modulates lipid metabolism and cell state
por: Eriksson, Ove, et al.
Publicado: (2017)

Wilms' tumour and parental age: a report from the National Wilms' Tumour Study.
por: Olson, J. M., et al.
Publicado: (1993)

Studies of Wilms’ Tumor (WT1) Gene Expression in Adult Acute Leukemias in Singapore
por: Lim, Che Kang, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0beos7fbfj0o761rg1t4pigq06